SPG11 and Alzheimer disease: Collectively, findings from related conditions—such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and traumatic brain injury—suggest that targeted dietary modulation may offer complementary benefits for managing metabolic and neurodegenerative dysfunction in SPG11 [3,14,26].